EXPD vs NRIX · P/E 26, rev $10.60B vs rev $54.5M
Expeditors International of Washington, Inc. (EXPD) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the EXPD and NRIX stock pages for the full models.
Not investment advice.